Abu Dhabi's G42, Mubadala combine healthcare assets

Top Stories

M42 will be led by Hasan Jasem Al Nowais, group chief executive officer and managing director. - WAM
M42 will be led by Hasan Jasem Al Nowais, group chief executive officer and managing director. - WAM

Published: Mon 17 Apr 2023, 1:51 PM

Last updated: Mon 17 Apr 2023, 4:37 PM

G42 and Mubadala Investment Company have combined their healthcare assets into a new company named M42, they said in a joint statement on Monday.

by

Ashwani Kumar

  • Follow us on
  • google-news
  • whatsapp
  • telegram

M42 combines G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class patient services and state-of-the-art facilities to provide the highest level of personalised, precise, and preventative care.

M42 is set to transform the way care is delivered, bridging the gap between the latest healthtech advancements and the clinical outcomes patients receive. It is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges.

Led by Hasan Jasem Al Nowais, group CEO and managing director, M42 will look at opportunities for global expansion and partnerships with pharmaceutical, healthcare, and healthtech leaders to bring high-quality care to communities around the world.

“As we launch M42, we are excited to impactfully disrupt the global healthcare industry. Our vision is to transform lives through innovation by providing personalised, and precise patient care. We are confident that through our operating companies, M42 will create a future in which dedicated healthcare professionals are empowered by the latest technology to optimize patient outcomes. M42 also represents a platform for us to target international expansion and partner with global peers to solve the world’s most pressing healthcare challenges,” Al Nowais said.

M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, HealthPoint Hospital, the HealthPlus network of specialty centres, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organisation and Solutions (IROS), Omics Centre of Excellence and The National Reference Laboratory, among others.

In October 2022, G42 Healthcare and Mubadala Health announced that they had joined forces to create a new, integrated healthcare technology powerhouse.


More news from Business